glp 1 approved for mash Wegovy becomes first GLP-1RA to gain FDA approval MASH therapy enters a more

injectable, options GLP-1s might be changing typical consumer behavior, according to Jennifer Lake, PharmD and PhD, assistant professor at the University of Toronto

Patients typically observe significant reduction in fine lines, measurable improvement in skin firmness and density, better skin uniformity, and, for hair protocols, visible new growth and increased density

PMID 29019175

10.3390/pharmaceutics11020078 84 WanW.QinQ.XieL.ZhangH.WuF.StevensR

Finally, there are more invasive treatments like injectables, stents or even surgeries.In Agos case, two doctors recommended surgery

Whilst their primary indication remains glycaemic control, emerging evidence suggests GLP-1 receptor agonists exert effects beyond glucose metabolism